1. Alano, F. A., Webster, G.D.: Acute renal failure and pigmentation due to phenazopyridine (Pyridium). Ann. intern. Med. 72, 89–91 (1970).
2. ALEXANDER, W.D., EVANS, V., MACAULAY, A., GALLAGHER, T.F., LONDONS, J.: Metabolism of 35S–labeled antithyroid drugs in man. Brit. med. J. 1969II, 290–291.
3. ALPEN, E.L., MANDEL, H.G., RODWELL, V.W., SMITH, P. K.: The metabolism of 14C carboxyl salicylic acid in the dog and in man. J. Pharmacol, exp. Ther. 102, 150–155 (1951).
4. ANEX, L., FAVEZ, G., WILLA, C.: Comparaison entre les clearances rénales à l’inuline et au para–amino–hippurate et les concentrations sanguines d’éthambutol. Schweiz. med. Wschr. 102, 126–128 (1972).
5. ASATOOR, A.M., LONDON, D.R., MILNE, M. D., Simenhoff, M.L.: The excretion of pethidine and its derivatives. Brit. J. Pharmacol. 20, 285–298 (1963).